John M Hatcher

5PUBLICATIONS
30CO-AUTHORS
Immunogenetics (incl. genetic immunology)Tumour immunologyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 15, 2026
Discovery of JH-XIII-05-01, a First-in-Class Dual IRAK1/IRAK4 Degrader for MYD88 Mutant Lymphomas.

|Feb 11, 2026
Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia.

Hao Sun, Romanos Sklavenitis Pistofidis, Shirong Liu

|Jan 03, 2026
Discovery and Characterization of a First-In-Class HCK/BTK PROTAC DFCI-002-06 for the Treatment of MYD88 Mutated B Cell Malignancies.

John M Hatcher, Shirong Liu, Amanda Kofides

|Nov 18, 2022
Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors.

Clare F Malone, Minjee Kim, Gabriela Alexe

Pageof 1

Frequent Collaborators

2 joint publications

Andrew R Branagan

2 joint publications

Steven P Treon

2 joint publications

Jorge J Castillo

2 joint publications

Maria Luisa Guerrera